We participate in various international projects regarding treatment, diagnostics and disease mechanisms. This leads to both original scientific articles and various types of review articles.
This includes, among other things, research-based testing of new drugs, assessment of optimal infection prevention and treatment, establishment of new MG subgroups, assessment of core information in specific national disease registries, preparation of general treatment guidelines, epidemiological studies, practical patient follow-up in hospitals, and guidelines for optimal user participation.